| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 7, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph C. Papa, Perrigo's President and CEO will present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference on...
-
Jun 6, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that a federal court has ruled in its favor in patent litigation involving Famotidine Complete. Perrigo had been sued by Johnson &...
-
May 30, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter coated nicotine polacrilex...
-
May 8, 2007Third Quarter Sales $362 million, up 9%
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the third quarter of fiscal year 2007 ended March 31, 2007. Perrigo Company (in thousands, except per share amounts)...
-
May 2, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.045 per share, payable on June 19, 2007 to shareholders of record on...
-
May 1, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May...
-
Apr 27, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its third quarter fiscal 2007 on Tuesday, May 8, 2007 at approximately 8:00 a.m. (ET). The...
-
Apr 5, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the CIBC World Markets Biotechnology & Pharmaceuticals Conference on...
-
Mar 27, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced an organizational restructuring to further enhance the management of the Company's global operations. John Hendrickson has been named...
-
Mar 7, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has entered into a purchase agreement to acquire Qualis, Inc., a privately-owned manufacturer of store brand pediculicide...
-
Mar 6, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the Citigroup Small & Mid-Cap Conference on Tuesday, March 13, at 10:45...
-
Feb 22, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced the appointment by the Board of Directors of Ben-Zion Zilberfarb as a new director of the Company. Dr. Zilberfarb was appointed to...
-
Feb 8, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that the Board of Directors has authorized the repurchase of $60 million of the Company's common stock through February 8, 2009 under...
-
Feb 1, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical...
-
Feb 1, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the second quarter of fiscal year 2007 ended December 30, 2006. Perrigo Company (in thousands, except per share amounts)...
-
Jan 18, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its second quarter fiscal 2007 on Thursday, Feb. 1, 2007 at approximately 7:30 a.m. (ET). The...
-
Jan 4, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the 25th Annual JPMorgan Healthcare Conference on Thursday, January 11,...
-
Dec 21, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market Simvastatin Tablets, USP, 5 mg, 10 mg, 20...
-
Dec 19, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Ciclopirox Topical...
-
Dec 18, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that the U. S. Food & Drug Administration (FDA) has issued an approvable letter for Dexcel Pharma Technologies, Ltd.'s New Drug...
-
Nov 10, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.045 per share, payable on December 19, 2006 to shareholders of record...
-
Nov 9, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) has released the following information regarding its voluntary recall announced early this morning. The voluntary recall was tied to certain lots of...
-
Nov 9, 2006(Nationwide Recall of Acetaminophen 500 Mg Caplets)
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it has initiated a voluntary, nationwide product recall to the retail level of certain lots of its store brand Acetaminophen 500...
-
Oct 31, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for its fiscal year 2007 first quarter that ended September 30, 2006. Perrigo Company (in thousands, except per share...
-
Oct 24, 2006
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its first quarter fiscal 2007 on Tuesday, Oct. 31, 2006 at approximately 8:30 a.m. (ET). The...